Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates.
Jones, R N
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates. [electronic resource] - Diagnostic microbiology and infectious disease Apr 1995 - 209-13 p. digital
Publication Type: Journal Article
0732-8893
10.1016/0732-8893(94)00061-z doi
Anti-Infective Agents--pharmacology
Ciprofloxacin--pharmacology
Drug Resistance, Microbial
Fleroxacin--pharmacology
Fluoroquinolones
Microbial Sensitivity Tests--methods
Quinolones--pharmacology
Sensitivity and Specificity
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates. [electronic resource] - Diagnostic microbiology and infectious disease Apr 1995 - 209-13 p. digital
Publication Type: Journal Article
0732-8893
10.1016/0732-8893(94)00061-z doi
Anti-Infective Agents--pharmacology
Ciprofloxacin--pharmacology
Drug Resistance, Microbial
Fleroxacin--pharmacology
Fluoroquinolones
Microbial Sensitivity Tests--methods
Quinolones--pharmacology
Sensitivity and Specificity